Article citationsMore>>
Powell, H.S., Thompson, W.L., Luthe, M.A., Stern, R.C., Grossniklaus, D.A., Bloxham, D.D., Groden, D.L., Jacobs, M.R., DiScenna, A.O., Cash, H.A. and Klinger, D.J. (1983) Once-daily vs. continuous amino glycoside dosing: Efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin, and tobramycin. The Journal of Infectious Diseases, 147, 918-932.
doi:10.1093/infdis/147.5.918
has been cited by the following article:
-
TITLE:
Novel genomic biomarkers for acute gentamicin nephrotoxicity in dog
AUTHORS:
James Eric McDuffie, Jingjin Gao, Jingying Ma, David La, Anton Bittner, Manisha Sonee, Matthew Wagoner, Sandra Snook
KEYWORDS:
Biomarker; Gentamicin; Nephrotoxicity; Dog
JOURNAL NAME:
Open Journal of Molecular and Integrative Physiology,
Vol.3 No.3,
August
28,
2013
ABSTRACT:
Objectives: Novel biomarkers indicative of drug-induced
kidney injury (DIKI) in dogs would have significant application in
preclinical drug development. We conducted a feasibility study to identify
genomic expression profiles for monitoring progressive, acute DIKI in dogs.
Materials and Methods: Animals were intramuscularly administered either 0.9%
physiological saline or gentamicin (40 mg/kg/day) for 10 consecutive days
and euthanized on day 11. Serum and urine samples were collected at various
time points and kidney samples were collected at necropsy for biomarker
measurements. Results: Acute gentamicin-induced renal histopathology changes
were localized to the proximal convoluted tubules and characterized as slight-to-marked,
diffuse cortical-medullary tubular epithelial degeneration/necrosis. Serum creatinine
(sCr) and blood urea nitrogen (BUN) elevations suggestive of mild renal
dysfunction were first observed on days 7 to 8. Gentamicin-induced increased urinary kidney
injury molecule-1 (KIM-1) mRNA was observed on day 6 preceding
detectable elevations of sCr and/or BUN. Increased urinary KIM-1 mRNA
correlated with multifocal KIM-1 immunostaining in the corticomedullary tubular
epithelial cells. Microarray analysis revealed changes in additional mRNA
expression products detected in urine and/or kidney that should be further
investigated for use as potential biomarkers for acute gentamicin related
nephrotoxicity in dogs. Conclusion: These findings suggested the utility of
non-invasive urinary genomic parameters for monitoring acute DIKI in dogs.
Related Articles:
-
Sara Elisa Herrera-Rodriguez, Darwin Elizondo-Quiroga, Ikuri Alvarez-Maya
-
Richard C. K. Burdekin
-
Garth L. Nicolson, Gonzalo Ferreira de Mattos, Robert Settineri, Carlos Costa, Rita Ellithorpe, Steven Rosenblatt, James La Valle, Antonio Jimenez, Shigeo Ohta
-
Amir Mufaddel, Abdelaziz A. Omer, Mohamed Omar Salem
-
Adikwu Elias, Ogbuehi Ijeoma, Nkereuwem Jonathan Edikpo, Deo Oputiri, Oru-Bo Precious Geoffrey